Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
University of Washington
National Cancer Institute (NCI)